Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

Chiara Calatozzolo; Emanuela Maderna; Bianca Pollo; Maurizio Gelati; Carlo Marras; Antonio Silvani; Danilo Croci; Amerigo Boiardi; Andrea Salmaggi

Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

Chiara Calatozzolo, Emanuela Maderna, Bianca Pollo, Maurizio Gelati, Carlo Marras, Antonio Silvani, Danilo Croci, Amerigo Boiardi, Andrea Salmaggi

Research output: Contribution to journal › Article › peer-review

Abstract

Both clinical and biological features have been reported as prognostic factors in low-grade gliomas. Among these, histotype, tumor size, enhancement, age and genetic pattern. Microvessel density (MVD) has been correlated to clinical outcome in astrocytomas, but its impact in oligodendrogliomas and mixed tumors is not sure. The pro-angiogenic chemokine stromal cell-derived factor (SDF-1/CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) have been described in low-grade gliomas, with a correlation between CXCL12 expression and shorter time to progression (TTP). The intermediate filament Nestin is expressed in proliferating vessels. Platelet-derived growth factor B (PDGF-B) and its receptor PDGFR-b are also involved in angiogenesis and malignant progression in gliomas.

Original language	English
Pages (from-to)	827-832
Number of pages	6
Journal	Cancer Biology and Therapy
Volume	5
Issue number	7
Publication status	Published - Jul 2006

Keywords

CXCL12
MVD
Nestin
Oligoastrocytoma
Oligodendroglioma
PDGF-B
PDGFR-β
TTP

ASJC Scopus subject areas

Cancer Research
Oncology

Cite this

@article{d193a71f99304fe8a5b872bc87fbc5d9,

title = "Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas",

abstract = "Both clinical and biological features have been reported as prognostic factors in low-grade gliomas. Among these, histotype, tumor size, enhancement, age and genetic pattern. Microvessel density (MVD) has been correlated to clinical outcome in astrocytomas, but its impact in oligodendrogliomas and mixed tumors is not sure. The pro-angiogenic chemokine stromal cell-derived factor (SDF-1/CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) have been described in low-grade gliomas, with a correlation between CXCL12 expression and shorter time to progression (TTP). The intermediate filament Nestin is expressed in proliferating vessels. Platelet-derived growth factor B (PDGF-B) and its receptor PDGFR-b are also involved in angiogenesis and malignant progression in gliomas.",

keywords = "CXCL12, MVD, Nestin, Oligoastrocytoma, Oligodendroglioma, PDGF-B, PDGFR-β, TTP",

author = "Chiara Calatozzolo and Emanuela Maderna and Bianca Pollo and Maurizio Gelati and Carlo Marras and Antonio Silvani and Danilo Croci and Amerigo Boiardi and Andrea Salmaggi",

year = "2006",

month = jul,

language = "English",

volume = "5",

pages = "827--832",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

publisher = "Landes Bioscience",

number = "7",

}

TY - JOUR

T1 - Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

AU - Calatozzolo, Chiara

AU - Maderna, Emanuela

AU - Pollo, Bianca

AU - Gelati, Maurizio

AU - Marras, Carlo

AU - Silvani, Antonio

AU - Croci, Danilo

AU - Boiardi, Amerigo

AU - Salmaggi, Andrea

PY - 2006/7

Y1 - 2006/7

N2 - Both clinical and biological features have been reported as prognostic factors in low-grade gliomas. Among these, histotype, tumor size, enhancement, age and genetic pattern. Microvessel density (MVD) has been correlated to clinical outcome in astrocytomas, but its impact in oligodendrogliomas and mixed tumors is not sure. The pro-angiogenic chemokine stromal cell-derived factor (SDF-1/CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) have been described in low-grade gliomas, with a correlation between CXCL12 expression and shorter time to progression (TTP). The intermediate filament Nestin is expressed in proliferating vessels. Platelet-derived growth factor B (PDGF-B) and its receptor PDGFR-b are also involved in angiogenesis and malignant progression in gliomas.

AB - Both clinical and biological features have been reported as prognostic factors in low-grade gliomas. Among these, histotype, tumor size, enhancement, age and genetic pattern. Microvessel density (MVD) has been correlated to clinical outcome in astrocytomas, but its impact in oligodendrogliomas and mixed tumors is not sure. The pro-angiogenic chemokine stromal cell-derived factor (SDF-1/CXCL12) and its receptor CXC chemokine receptor 4 (CXCR4) have been described in low-grade gliomas, with a correlation between CXCL12 expression and shorter time to progression (TTP). The intermediate filament Nestin is expressed in proliferating vessels. Platelet-derived growth factor B (PDGF-B) and its receptor PDGFR-b are also involved in angiogenesis and malignant progression in gliomas.

KW - CXCL12

KW - MVD

KW - Nestin

KW - Oligoastrocytoma

KW - Oligodendroglioma

KW - PDGF-B

KW - PDGFR-β

KW - TTP

UR - http://www.scopus.com/inward/record.url?scp=33751196377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751196377&partnerID=8YFLogxK

M3 - Article

C2 - 16760646

AN - SCOPUS:33751196377

VL - 5

SP - 827

EP - 832

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 7

ER -

Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this